ID: 129664821 | ReSE screen-validated silencer GRCh37_chr22:23975547-23975684 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23633360..23633497) | | |
ID: 127895539 | H3K4me1 hESC enhancer GRCh37_chr22:23991555-23992054 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23649368..23649867) | | |
ID: 127895538 | H3K4me1 hESC enhancer GRCh37_chr22:23891199-23891699 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23549012..23549512) | | |
ID: 125424394 | Sharpr-MPRA regulatory region 8041 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23565282..23565576) | | |
ID: 125424393 | Sharpr-MPRA regulatory region 4313 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23538122..23538914) | | |
ID: 124905089 | uncharacterized LOC124905089 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23632876..23637732, complement) | | |
ID: 124900476 | endogenous retrovirus group K member 5 Gag polyprotein-like [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23536881..23547805) | | |
ID: 111828506 | Sharpr-MPRA regulatory regions 962 and 2236 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23539602..23539916) | | |
ID: 105372957 | uncharacterized LOC105372957 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23566970..23573098) | | |
ID: 101978785 | prostate cancer associated transcript 14 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23538102..23547306) | | |
ID: 91316 | GUSB pseudogene 11 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23638487..23717423, complement) | | |
ID: 51233 | aspartate rich 1 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23580880..23632816, complement) | C22orf43, KB-208E9.1 | |
ID: 3543 | immunoglobulin lambda like polypeptide 1 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23573125..23580290, complement) | 14.1, AGM2, CD179b, IGL1, IGL5, IGLJ14.1, IGLL, IGO, IGVPB, VPREB2 | 146770 |
ID: 436 | argininosuccinate lyase pseudogene 1 [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23648669..23653359, complement) | ASLL | |